Spike protein (IMAGE)

Northwestern University

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.

Media Contact

Amanda Morris
Northwestern University
amandamo@northwestern.edu
Office: 847-467-6790

Expert Contact

Michael Jewett
Northwestern University
m-jewett@northwestern.edu
@NorthwesternU

New COVID-19 nasal spray outperforms current antibody treatments in mice

Northwestern University

Journal: Science Translational Medicine
Funder: Bill and Melinda Gates Foundation, Burroughs Wellcome Fund, Camille and Henry Dreyfus Foundation, David and Lucile Packard Foundation, Helen Hay Whitney Foundation, Open Philanthropy Project, Pew Charitable Trusts, Wu Tsai Neurosciences Institute, Howard Hughes Medical Institute, U.S. Department of Defense, Defense Advanced Research Projects Agency, Defense Threat Reduction Agency, European Commission, NIH/National Institutes of Health, NIH/National Institute of Allergy and Infectious Diseases, NIH/National Institute of Diabetes and Digestive and Kidney Diseases, NIH/National Institute of General Medical Sciences, NIH/National Center for Advancing Translational Sciences (NCATS), United World Antiviral Research Network, Department of Health and Human Services
DOI: 10.1126/scitranslmed.abn1252

Keywords

/Health and medicine/Clinical medicine/Medical treatments/Drug therapy/Medications/Antivirals
/Health and medicine/Diseases and disorders/Infectious diseases/Microbial infections/Viral infections/COVID 19

Additional Multimedia

Spike protein

Original Source

https://news.northwestern.edu/stories/2022/04/new-covid-19-nasal-spray-outperforms-current-antibody-treatments-in-mice/&fj=1

facebook.com/EurekAlert
@EurekAlert
youtube.com/EurekAlert

Help / FAQ
Services
Eligibility Guidelines
Contact EurekAlert!

Terms & Conditions
DMCA
Privacy Policy
Disclaimer

Spike protein (IMAGE)

Caption

Credit

Usage Restrictions

License